(0.05%) 5 310.78 points
(0.08%) 39 940 points
(0.02%) 16 746 points
(0.78%) $79.24
(3.10%) $2.49
(-0.44%) $2 384.40
(0.44%) $29.86
(-0.20%) $1 068.00
(0.15%) $0.920
(0.27%) $10.69
(0.08%) $0.789
(0.25%) $90.91
Live Chart Being Loaded With Signals
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies...
Stats | |
---|---|
Today's Volume | 24 271.00 |
Average Volume | 191 868 |
Market Cap | 256.00M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.500 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.390 |
ATR14 | $0.0200 (0.65%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-06 | Russotti Gregory | Sell | 5 000 | Common Stock |
2024-05-03 | Carr Douglas | Sell | 257 | Common Stock |
2024-05-03 | Farid Adrienne | Sell | 913 | Common Stock |
2024-04-22 | Russotti Gregory | Sell | 5 000 | Common Stock |
2024-03-07 | Pfeiffenberger Brent | Buy | 17 425 | Common Stock |
INSIDER POWER |
---|
69.62 |
Last 96 transactions |
Buy: 10 700 785 | Sell: 13 077 886 |
Volume Correlation
Century Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Century Therapeutics, Correlation - Currency/Commodity
Century Therapeutics, Financials
Annual | 2023 |
Revenue: | $2.24M |
Gross Profit: | $-10.81M (-483.62 %) |
EPS: | $-2.30 |
FY | 2023 |
Revenue: | $2.24M |
Gross Profit: | $-10.81M (-483.62 %) |
EPS: | $-2.30 |
FY | 2022 |
Revenue: | $5.20M |
Gross Profit: | $-4.87M (-93.71 %) |
EPS: | $-2.27 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.759 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Century Therapeutics,
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators